LCN2 and acute kidney injury: New biomarkers, such as liver-type fatty acid-binding protein (u-LFABP), neutrophil gelatinase-associated lipocalin (NGAL), connective tissue growth factor (CTGF), and Interleukin 18 (IL-18), provide a promising future as AKI biomarkers for kidney function.